Thus, enhanced expression of hepatic CD14 by leptin may increase hepatic responsiveness to gut microbiota-derived endotoxins even at low levels, resulting in the progression from simple steatosis to NASH via STAT3 signaling. The gene discussed is STAT3; the disease is steatosis.